Since we could show that UGCG leads to glutamine dependency in MCF-7 cells, which results in increased glycolysis, OXPHOS (current study) and cell proliferation22, pharmacological inhibition of both glutamine metabolism and GlcCer synthesis via UGCG could be beneficial for treatment of breast cancer patients. Here, UGCG is linked to breast carcinoma.